13:36:49 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-21 Bokslutskommuniké 2024
2024-11-08 Kvartalsrapport 2024-Q3
2024-07-25 Kvartalsrapport 2024-Q2
2024-06-05 X-dag ordinarie utdelning CCC 0.00 SEK
2024-06-04 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-23 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-07-28 Kvartalsrapport 2023-Q2
2023-06-02 X-dag ordinarie utdelning CCC 0.00 SEK
2023-06-01 Årsstämma 2023
2023-04-27 Kvartalsrapport 2023-Q1
2023-03-17 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-30 Kvartalsrapport 2022-Q3
2022-07-27 Kvartalsrapport 2022-Q2
2022-05-19 X-dag ordinarie utdelning CCC 0.00 SEK
2022-05-18 Årsstämma 2022
2022-04-29 Kvartalsrapport 2022-Q1
2022-03-30 Bokslutskommuniké 2021
2021-10-29 Kvartalsrapport 2021-Q3
2021-07-30 Kvartalsrapport 2021-Q2
2021-05-28 X-dag ordinarie utdelning CCC 0.00 SEK
2021-05-27 Årsstämma 2021
2021-04-30 Kvartalsrapport 2021-Q1
2021-02-26 Bokslutskommuniké 2020
2020-10-30 Kvartalsrapport 2020-Q3
2020-07-24 Kvartalsrapport 2020-Q2
2020-05-14 X-dag ordinarie utdelning CCC 0.00 SEK
2020-05-13 Årsstämma 2020
2020-04-30 Kvartalsrapport 2020-Q1
2020-02-21 Bokslutskommuniké 2019
2019-11-08 Kvartalsrapport 2019-Q3
2019-07-31 Kvartalsrapport 2019-Q2
2019-05-13 X-dag ordinarie utdelning CCC 0.00 SEK
2019-05-10 Årsstämma 2019
2019-05-03 Kvartalsrapport 2019-Q1
2019-02-21 Bokslutskommuniké 2018
2018-11-02 Kvartalsrapport 2018-Q3
2018-08-03 Kvartalsrapport 2018-Q2
2018-05-04 Kvartalsrapport 2018-Q1
2018-04-13 X-dag ordinarie utdelning CCC 0.02 SEK
2018-04-12 Årsstämma 2018
2018-02-23 Bokslutskommuniké 2017
2017-10-31 Kvartalsrapport 2017-Q3
2017-08-02 Kvartalsrapport 2017-Q2
2017-06-09 X-dag ordinarie utdelning CCC 0.45 SEK
2017-05-03 Kvartalsrapport 2017-Q1
2017-03-29 Årsstämma 2017
2017-02-22 Bokslutskommuniké 2016
2016-11-03 Kvartalsrapport 2016-Q3
2016-08-04 Kvartalsrapport 2016-Q2
2016-07-01 X-dag ordinarie utdelning CCC 0.25 SEK
2016-05-10 Kvartalsrapport 2016-Q1
2016-04-22 Årsstämma 2016
2016-02-25 Bokslutskommuniké 2015
2015-11-05 Kvartalsrapport 2015-Q3
2015-08-05 Kvartalsrapport 2015-Q2
2015-07-01 X-dag ordinarie utdelning CCC 0.44 SEK
2015-05-06 Kvartalsrapport 2015-Q1
2015-04-22 Årsstämma 2015
2015-02-26 Bokslutskommuniké 2014
2014-11-06 Kvartalsrapport 2014-Q3
2014-11-06 Analytiker möte 2014
2014-08-07 Kvartalsrapport 2014-Q2
2014-05-06 Kvartalsrapport 2014-Q1
2014-04-24 X-dag ordinarie utdelning CCC 0.36 SEK
2014-04-23 Årsstämma 2014
2014-02-26 Bokslutskommuniké 2013
2013-11-07 Analytiker möte 2013
2013-11-07 Kvartalsrapport 2013-Q3
2013-08-08 Kvartalsrapport 2013-Q2
2013-05-06 Kvartalsrapport 2013-Q1
2013-04-24 X-dag ordinarie utdelning CCC 0.35 SEK
2013-04-23 Årsstämma 2013
2013-02-26 Bokslutskommuniké 2012
2012-11-12 Kvartalsrapport 2012-Q3
2012-11-12 Analytiker möte 2012
2012-08-09 Kvartalsrapport 2012-Q2
2012-05-07 Kvartalsrapport 2012-Q1
2012-05-04 Årsstämma 2012
2012-02-29 Bokslutskommuniké 2011
2011-11-16 Kvartalsrapport 2011-Q3

Beskrivning

LandSchweiz
ListaMid Cap Stockholm
SektorIndustri
IndustriIndustriprodukter
Cavotec är en industrikoncern. Inom koncernen återfinns ett brett utbud av ingenjörstjänster för sektorerna sjöfart, gruva, industri och flyg. Lösningarna innefattar strömförsörjning av kranar, rälsar, kablar och kontrollsystem. Koncernen har ett ingenjörsnätverk på global nivå och verksamhet innehas inom Europa och Nordamerika. Huvudkontoret ligger i Lugano, Schweiz.
2023-02-22 17:35:00

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, HONG KONG, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES BESIDES THOSE REQUIRED BY SWEDISH LAW. ADDITIONAL RESTRICTIONS APPLY, PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE

Cavotec SA (publ) (”Cavotec” or the ”Company”) (Nasdaq Stockholm: CCC) intends to explore the conditions to carry out a directed new issue of approximately SEK 165 million, to Swedish and international institutional investors through an accelerated bookbuilding procedure (the “Share Issue”). Cavotec has appointed Skandinaviska Enskilda Banken AB (”SEB”) as Sole Bookrunner to explore the conditions to carry out the Share Issue. The Company’s largest shareholders Bure Equity and Thomas von Koch are prepared to participate in the Share Issue.
 
The purpose of the Share Issue is to increase financial flexibility to support the company to execute on its strong order book, growth plans and in addition strengthen the Company’s financial position by reducing net debt. Going forward Cavotec remains committed to leverage its market leading positions, with a strong focus on profitability and cash flows, and thereby play a vital role in the technological shift to a more sustainable world. 
 
The Share Issue is intended to be carried out with exclusion of the shareholders’ pre-emptive rights, and to be resolved by an extraordinary general meeting to be held on 17 March 2023 and implemented by the board of directors thereafter based on such resolution. The subscription price and the total number of shares will be determined through an accelerated bookbuilding procedure conducted by SEB, which will commence immediately after the publication of this press release. Pricing and allocation are expected to take place before the commencement of trading on Nasdaq Stockholm on 23 February 2023. By establishing the subscription price through an accelerated bookbuilding procedure, it is the assessment of the board of directors that the subscription price will accurately reflect current market conditions and demand. The closing, pricing and allocation of the bookbuilding procedure is at the discretion of the Company and may be cancelled at any time. The Company will announce the outcome in a subsequent press release after the bookbuilding procedure has been completed.
 
The board of directors has carefully considered the option to carry out a rights issue in order to raise the requisite proceeds. In the evaluation, the board of directors has considered, among other things, the following factors: that a rights issue, compared to the Share Issue (i) would be significantly more time consuming, which would lead to risks that the Company loses potential growth opportunities, (ii) would entail higher total costs for the Company, mainly due to procurement of a guarantee consortium and prospectus administration etc., (iii) would expose the Company to market volatility, especially considering current market conditions, and (iv) likely would have had to be made at a lower subscription price, which may be to the disadvantage of the shareholders. Against this background, the board of director’s overall assessment is that the reasons for carrying out the Share Issue in this manner overweigh, in this particular case, the principal rule that new share issues shall be carried out with pre-emptive rights for existing shareholders, and that a new share issue with exclusion of the shareholders’ pre-emptive rights is in the interest of the Company’s shareholders.
 
Provided that the accelerated bookbuilding is successful, an extraordinary general meeting will be convened to approve the Share Issue. Some of the Company’s existing shareholders, including Bure Equity and Thomas von Koch, together holding approximately 47 percent of the shares and votes in Cavotec, have undertaken to vote in favour thereof at the extraordinary general meeting.
 
Financial and legal advisors
Skandinaviska Enskilda Banken is acting as Sole Bookrunner in connection with the Share Issue. KANTER is acting as legal advisor in relation to Swedish law to Cavotec and Bär & Karrer SA is acting as legal advisors in relation to Swiss law.